For in vitro diagnostic use. Others CRPHS IVD CRPHS CPS_000086 Cardiac C-Reactive Protein (Latex) High Sensitive 05401607190 CRP HS 100T cobas c111 CRPHS 04015630926916 Reagents, kits 2 × 50 tests cobas c 111 true 04628918190 CRP LX HS, 300Tests, cobas c, Integra CRPHS 04015630921508 Reagents, kits 300 tests COBAS INTEGRA 400 Plus, cobas c 311/501/502 true 05950864190 CRPHS 250Tests cobas c 701 CRPHS 04015630928774 Reagents, kits 250 tests cobas c 701/702 true 08057605190 CRPHS, 600T, cobas c pack green CRPHS 07613336121207 Reagents, kits 600 tests cobas c 303/503/703 true 05403138001 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 10 FF000000067E0B0E FF000000003B880E 05401607190 307 cobas c 111 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on the cobas c 111 system. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0205401607190c111 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 9 FF0000000671F80E FF0000000671F80E 05401607190 307 cobas c 111 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on the cobas c 111 system. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0204628918190COIN CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 12 FF00000006AB370E FF0000000671FA0E 04628918190 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on COBAS INTEGRA systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 04628918500 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 14 FF00000006596D0E FF0000000024A80E 04628918190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c and COBAS INTEGRA systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0004628918190COIN CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 10 FF00000004A36A0E FF0000000166CE0E 04628918190 304 COBAS INTEGRA 800 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on COBAS INTEGRA systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 04628918500 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 15 FF000000067CB90E FF0000000024A70E 04628918190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c and COBAS INTEGRA systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0204628918190c501 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 15 FF00000006AB300E FF0000000671710E 04628918190 308 cobas c 311 2324 cobas c 502 309 cobas c 501 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 05950864500 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 11 FF000000067D320E FF000000003BC30E 05950864190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0205950864190c701 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 11 FF00000006AB350E FF0000000671700E 05950864190 2492 cobas c 702 310 cobas c 701 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 08057605500 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 9 FF000000069F000E FF0000000488050E 08057605190 10299 cobas c 703 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en 0208057605190c503 CRPHS Cardiac C-Reactive Protein (Latex) High Sensitive en 7 FF00000006AB2F0E FF00000005AC070E 08057605190 9493 cobas c 303 8481 cobas c 503 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of C‑reactive protein (CRP) in human serum and plasma on cobas c systems. Measurement of CRP is of use for the detection and evaluation of inflammatory disorders and associated diseases, infection and tissue injury. Highly sensitive measurement of CRP may also be used as an aid in the assessment of the risk of future coronary heart disease. When used as an adjunct to other laboratory evaluation methods of acute coronary syndromes, it may also be an additional independent indicator of recurrent event prognosis in patients with stable coronary disease or acute coronary syndrome. en